Abstract

The incidence of insulin resistance (IR) and hepatic steatosis is increasing, with dietary fiber playing a protective role against these disorders. Ocimum basilicum L., widely used in food, pharmaceutical, and cosmetic industries, but their health-promoting properties remain underexplored. This study evaluated the effects of a fiber-rich fraction of partially defatted basil seeds (BSF) on IR, hepatic steatosis, and polyunsaturated fatty acid and short-chain fatty acid (SCFA) profiles in high-fat diet (HFD)-fed C57BL/6 J male mice. Mice were assigned to four groups and fed either a control diet or HFD, supplemented with BSF or oat flour for 4 weeks. HFD induced IR, hepatic steatosis, proinflammatory state, and a significant decreased in SCFA production. In contrast, supplementation with BSF attenuated IR, steatosis, liver damage, oxidative stress, and inflammation, while increasing n-3 polyunsaturated fatty acids in liver, adipocytes, and erythrocytes, and enhancing SCFA production, suggesting potential therapeutic benefits in managing these conditions.

Details

Title
High-fiber basil seed flour reduces insulin resistance and hepatic steatosis in high-fat diet mice
Author
Farías, Camila 1   VIAFID ORCID Logo  ; Cisternas, Camila 2   VIAFID ORCID Logo  ; Caicedo, Angie 3 ; Mercado, Lorena 4 ; Valenzuela, Rodrigo 1   VIAFID ORCID Logo  ; Calderón, Héctor 5 ; Espinosa, Alejandra 6 ; Videla, L. A. 7 ; Muñoz, Loreto A. 5   VIAFID ORCID Logo 

 University of Chile, Nutrition Department, Faculty of Medicine, Santiago, Chile (GRID:grid.443909.3) (ISNI:0000 0004 0385 4466) 
 Universidad San Sebastián, School of Health Care Sciences , Puerto Montt, Chile (GRID:grid.442215.4) (ISNI:0000 0001 2227 4297) 
 Pontificia Universidad Católica de Valparaíso, School of Agronomy, Faculty of Agronomy and Food Sciences , Quillota, 2260000, Chile (GRID:grid.8170.e) (ISNI:0000 0001 1537 5962) 
 University of Chile, Nutrition Department, Faculty of Medicine, Santiago, Chile (GRID:grid.443909.3) (ISNI:0000 0004 0385 4466); Facultad Medicina, Universidad Andrés Bello, Medicina, Santiago, Chile (GRID:grid.412848.3) (ISNI:0000 0001 2156 804X) 
 Universidad Central de Chile, Food Science Lab, Faculty of Medicine and Health Sciences, Santiago, Chile (GRID:grid.440619.e) (ISNI:0000 0001 2111 9391) 
 Center of Interdisciplinary Biomedical and Engineering Research for Health-MEDING. Universidad de Valparaíso, Valparaíso, Chile (GRID:grid.412185.b) (ISNI:0000 0000 8912 4050); University of Chile, Medical Technology Department, Faculty of Medicine, Santiago, Chile (GRID:grid.443909.3) (ISNI:0000 0004 0385 4466) 
 Universidad de Chile, Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, Santiago, Chile (GRID:grid.443909.3) (ISNI:0000 0004 0385 4466) 
Pages
90
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
23968370
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3126245635
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.